• Explore /
  • Poster
  • / Results from phase I/II study of NY-ESO-1-specific TCR gene-transduced T cell therapy (TBI-1301, mipetresgene autoleucel) in patients with advanced synovial sarcoma.

Results from phase I/II study of NY-ESO-1-specific TCR gene-transduced T cell therapy (TBI-1301, mipetresgene autoleucel) in patients with advanced synovial sarcoma.

Abstract Poster

Authors

null

Akira Kawai

Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan

Akira Kawai , Mikiya Ishihara , Tomoki Nakamura , Shigehisa Kitano , Shintaro Iwata , Kohichi Takada , Makoto Emori , Koji Kato , Makoto Endo , Yoshihiro Matsumoto , Shigeki Kakunaga , Eiichi Sato , Yoshihiro Miyahara , Kunihiko Morino , Shinya Tanaka , Shuichi Takahashi , Akihiko Matsumine , Shinichi Kageyama , Takafumi Ueda

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Sarcoma

Track

Sarcoma

Sub Track

Soft Tissue Tumors

Clinical Trial Registration Number

NCT03250325

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 11558)

DOI

10.1200/JCO.2023.41.16_suppl.11558

Abstract #

11558

Poster Bd #

492

Abstract Disclosures

Similar Posters

First Author: Marcus O. Butler

First Author: Mikiya Ishihara

Poster

2024 ASCO Annual Meeting

<span>Phase IIA study of high-affinity TCR-T (TAEST16001) targeting NY-ESO-1 in soft tissue sarcoma.</span>

Phase IIA study of high-affinity TCR-T (TAEST16001) targeting NY-ESO-1 in soft tissue sarcoma.

First Author: Jiayong Liu

First Author: Dejka M. Araujo